An app partnership to reach epilepsy patients for an AI study [case study]

An academic research center set out to determine whether artificial intelligence (AI) could effectively predict optimal anti-epileptic treatment choices for patients. They partnered with an AI platform to run an observational study and tapped Antidote to find and engage potential participants. Together, we developed a customized recruitment plan to reach epilepsy patients, encourage them to download the AI platform app, and enroll in the study.

Download the case study to learn about our full breadth of recruitment solutions for this trial, how our support ultimately delivered 48% of all enrolled patients for this study, and how we developed a great partnership with an AI platform app to help patients enroll in this trial.